CD4 and breast neoplasm: CD4+ T cells in highly infiltrated breast tumors of all subtypes are also phenotypically skewed towards the T follicular helper cells (TFH) phenotype, characterized by CD200, ICOS, CXCL13, and a high level of PD-1 [33].